Functional role of local angiotensin-converting enzyme (ACE) in adrenal catecholamine secretion in vivo

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 11, 1999, Pages 878-885

  Yamaguchi, Nobuharu ^a   Martineau, Daniel ^a   Lamouche, Stéphane ^a   Briand, Richard ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Bristol Myers Squibb Canada   (Canada)

Author keywords

Adrenal gland; Anesthetized dog; Angiotensin I; Angiotensin II; Captopril

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DOG; HYPERTENSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL;

EID: 0033375656     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-094     Document Type: Article

References (28)

1. Andersson, K.E., Hedlun, H., and Stahl, M. 1992. Contractions induced by angiotensin I, angiotensin II and bradykinin in isolated smooth muscle from the human detrusor. Acta Physiol. Scand. 145: 253-259.
2. Benjamin, N., Cockcroft, J.R., Collier, J.G., Dollery, C.T., Ritter, J.M., and Webb, D.J. 1989. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J. Physiol. (London), 412: 543-555.
3. Braley, L.M., Menachery, A., and Williams, G.H. 1981. Angiotensin II's role in mediating angiotensin I-and tetradecapeptide-induced steroidogenesis by rat glomerulosa cells. Endocrinology, 109: 960-965.
4. Chai, S.Y., Allen, A.M., Adam, W.R., and Mendelsohn, F.A.O. 1986. Local actions of angiotensin II: quantitative in vitro autoradiographic localization of angiotensin II receptor binding and angiotensin converting enzyme in target tissues. J. Cardiovasc. Pharmacol. 8(Suppl. 10): S35-S39.
5. Danser, A.H.J. 1996. Local renin-angiotensin systems. Mol. Cell. Biochem. 157: 211-216.
6. Eguchi, T., Saito, I., Nakamura, R., Yasui, T., and Saruta, T. 1980. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone. Acta Endocrinol. 94: 213-220.
7. Eichler, H.G., Blochl-Daum, B., and Gasic, S. 1989. Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties. J. Cardiovasc. Pharmacol. 14: 248-252.
8. Feuerstein, G., and Cohen, S. 1979. Modification by SQ 14225 of blood pressure and adrenal catecholamine response to haemorrhage. Eur. J. Pharmacol. 55: 203-206.
9. Israel, A., Barbella, Y., and Saavedra, J.M. 1986. Compensatory increase in adrenomedullary angiotensin-converting enzyme activity (kininase II) after unilateral adrenalectomy. Regul. Pept. 16: 97-105.
10. Johnston, C.I. 1992. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J. Hypertens. 10: S13-S26.
11. Kahan, T., Lindqvist, M., Nussberger, J., Melcher, A., and Hjemdahl, P. 1997. Plasma angiotensins and human forearm circulation: effects of sympatho-adrenal activation. Acta Physiol. Scand. 159: 107-111.
12. Kimura, T., Suzuki, Y., Yoneda, H., Suzuki-Kusaba, M., and Satoh, S. 1992. Facilitatory role of the renin-angiotensin system in controlling adrenal catecholamine release in hemorrhaged dogs. J. Cardiovasc. Pharmacol. 19: 975-981.
13. Laliberte, F., Laliberte, M.F., Alhenc-Gelas, F., and Chevillard, C. 1987. Cellular and subcellular immunohistochemical localization of angiotensin-converting enzyme in the rat adrenal gland. Lab. Invest. 56: 364-371.
14. Madsen, B.K., Holmer, P., Ibsen, H., and Christensen, N.J. 1992. The influence of captopril on the epinephrine response to insulin-induced hypoglycemia in humans. The interaction between the renin-angiotensin system and the sympathetic nervous system. Am. J. Hypertens. 5: 361-365.
15. 1 antagonist, of adrenal catecholamine release induced by angiotensin II in the dog in vivo. Can. J. Physiol. Pharmacol. 73: 459-464.
16. Nakamura, M., Misono, K.S., Naruse, M., Workman, R.J., and Inagami, T. 1985. A role for the adrenal renin-angiotensin system in the regulation of potassium-stimulated aldosterone production. Endocrinology, 117: 1772-1778.
17. Ng, K.K.F.V., Jr. 1967. Conversion of angiotensin I to angiotensin II. Nature (London), 216: 762-766.
18. Oda, H., Lotshaw, D.P., Franco-Saenz, R., and Mulrow, P.J. 1991. Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules. Proc. Soc. Exp. Biol. Med. 196: 175-177.
19. Peach, M.J. 1971. Adrenal medullary stimulation induced by angiotensin I, angiotensin II, and analogues. Circ. Res. 28 and 29(Suppl. II): II-107-II-116.
20. Peach, M.J., Bumpus, F.M., and Khairallah, P.A. 1971. Release of adrenal catecholamines by angiotensin I. J. Pharmacol. Exp. Ther. 176: 366-376.
21. Peters, J., Kranzlin, B., Schaeffer, S., Zimmer, J., Resch, S., Bachmann, S., Gretz, N., and Hachenthal, E. 1996. Presence of renin intramitochondrial dense bodies of the rat adrenal cortex. Am. J. Physiol. 271: E439-E450.
22. Phillips, M.I., Speakman, E.A., and Kimura, B. 1993. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul. Pept. 43: 1-20.
23. Schwieler, J.H., Nussberger, J., Kahan, T., and Hjemdahl, P. 1994. Angiotensin II overflow from canine skeletal muscle in vivo: importance of plasma angiotensin I. Am. J. Physiol. 266: R1664-R1669.
24. 3H] captopril autoradiography. Endocrinology, 118: 1690-1699.
25. Svane, D., Kahr, O., Hansen, V.B., Holm-Nielsen, P., and Forman, A. 1995. Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries. Am. J. Obstet. Gynecol. 172: 991-997.
26. Tokita, Y., Oda, H., Franco-Saenz, R., and Mulrow, P.J. 1995. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors. Proc. Soc. Exp. Biol. Med. 208: 391-396.
27. Wallenstein, S., Zucker, C.L., and Fleiss, J. 1980. Some statistical methods useful in circulation research. Circ. Res. 47: 1-9.
28. Yamaguchi, N. 1993. In vivo evidence for adrenal catecholamine release mediated by non-nicotinic mechanism: local medullary effect of VIP. Am. J. Physiol. 265: R766-R771.